[HTML][HTML] Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery
DA Richards - Drug Discovery Today: Technologies, 2018 - Elsevier
The field of targeted therapeutics has benefitted immeasurably from the development of high-
affinity antibodies. These important ligands have facilitated the development of effective …
affinity antibodies. These important ligands have facilitated the development of effective …
Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery
DA Richards - Drug discovery today. Technologies, 2018 - pubmed.ncbi.nlm.nih.gov
The field of targeted therapeutics has benefitted immeasurably from the development of high-
affinity antibodies. These important ligands have facilitated the development of effective …
affinity antibodies. These important ligands have facilitated the development of effective …
[引用][C] Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery
DA Richards - Drug Discovery Today: Technologies, 2018 - cir.nii.ac.jp
Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for
targeted drug delivery | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
targeted drug delivery | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery.
DA Richards - Drug Discovery today. Technologies, 2018 - europepmc.org
The field of targeted therapeutics has benefitted immeasurably from the development of high-
affinity antibodies. These important ligands have facilitated the development of effective …
affinity antibodies. These important ligands have facilitated the development of effective …